Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 2 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2023 Filed May 10, 2023 22:43 UTC |
Gurfein BlakeChief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0000899243-23-012533 · doc4.xml · derivative · entry 1 Gurfein Blake · CIK 0001891888 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-05-07 F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the 36 months thereafter. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 19:44 UTC |
Zikria DeanDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001104659-22-072042 · tm2218712-1_4seq1.xml · derivative · entry 1 Zikria Dean · CIK 0001877611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-06-13 F1 · derivative.exercise_date: The option vests as follows: (i) 50% one year from the grant date, and (ii) the remaining 50% in equal monthly installments over the next 24 months. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 23:45 UTC |
Bolton SheryleDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001104659-22-072043 · tm2218712-2_4seq1.xml · derivative · entry 1 Bolton Sheryle · CIK 0001418947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-06-13 F1 · derivative.exercise_date: The option vests as follows: (i) 50% one year from the grant date, and (ii) the remaining 50% in equal monthly installments over the next 24 months. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 23:47 UTC |
Drexler KarenDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001104659-22-072045 · tm2218712-3_4seq1.xml · derivative · entry 1 Drexler Karen · CIK 0001504699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-06-13 F1 · derivative.exercise_date: The option vests as follows: (i) 50% one year from the grant date, and (ii) the remaining 50% in equal monthly installments over the next 24 months. Read SEC document |
| June 14, 2022 Filed Jun 21, 2022 17:23 UTC Amendment |
Zikria DeanDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001104659-22-073070 · tm2218957-1_4aseq1.xml · derivative · entry 1 Zikria Dean · CIK 0001877611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-06-13 F1 · derivative.exercise_date: This Amendment No. 1 ("Form 4/A") to the Form 4 filed by the reporting person on June 16, 2022 (the "Original Form 4") is being filed to correct an administrative error, resulting in the incorrect versting schedule being included for the option. As reflected in this Form 4/A, the option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date. Read SEC document |
| June 14, 2022 Filed Jun 21, 2022 21:24 UTC Amendment |
Bolton SheryleDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001104659-22-073073 · tm2218957-3_4aseq1.xml · derivative · entry 1 Bolton Sheryle · CIK 0001418947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-06-13 F1 · derivative.exercise_date: This Amendment No. 1 ("Form 4/A") to the Form 4 filed by the reporting person on June 16, 2022 (the "Original Form 4") is being filed to correct an administrative error, resulting in the incorrect versting schedule being included for the option. As reflected in this Form 4/A, the option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date. Read SEC document |
| June 14, 2022 Filed Jun 21, 2022 21:23 UTC Amendment |
Drexler KarenDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001104659-22-073071 · tm2218957-2_4aseq1.xml · derivative · entry 1 Drexler Karen · CIK 0001504699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-06-13 F1 · derivative.exercise_date: This Amendment No. 1 ("Form 4/A") to the Form 4 filed by the reporting person on June 16, 2022 (the "Original Form 4") is being filed to correct an administrative error, resulting in the incorrect versting schedule being included for the option. As reflected in this Form 4/A, the option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date. Read SEC document |
| May 16, 2022 Filed Feb 14, 2023 23:34 UTC |
Drexler KarenDirector
|
OtherCommon Stock | 15,111 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005056 · doc5.xml · nonDerivative · entry 1 Drexler Karen · CIK 0001504699 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Drexler Family Trust U/D/T dated May 23, 1996 Disclosed balance after: 18,076 F1 · kind: Represents a pro rata distribution from Astia Angels Tivic LLC, of which the reporting person was a member, in connection with the dissolution of such entity. F1 · price: Represents a pro rata distribution from Astia Angels Tivic LLC, of which the reporting person was a member, in connection with the dissolution of such entity. F2 · ownership.nature: These shares are owned directly by the Drexler Family Trust U/D/T dated May 23, 1996, and indirectly by the reporting person as trustee of such trust. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 17:15 UTC |
Cai VeronicaChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 117,880 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001104659-22-042855 · tm2211723d2_4.xml · derivative · entry 1 Cai Veronica · CIK 0001801322 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,880 Underlying: Common Stock · 117,880 shares Expires 2032-03-31 F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the 36 months thereafter. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 17:34 UTC |
Ernst JenniferDirector · Chief Executive Officer · 10% owner
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001104659-22-014166 · tm225821d2_4.xml · derivative · entry 1 Ernst Jennifer · CIK 0001889915 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-02-03 F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 22:35 UTC |
Sabia RyanChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001104659-22-014171 · tm225821d3_4.xml · derivative · entry 1 Sabia Ryan · CIK 0001892415 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-02-03 F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 22:32 UTC |
Gurfein BlakeChief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001104659-22-014161 · tm225821d1_4.xml · derivative · entry 1 Gurfein Blake · CIK 0001891888 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-02-03 F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 20:38 UTC |
Zikria DeanDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $4.59 | $0.00 |
DisclosureSEC source: 0001104659-21-150713 · tm2135733d3_4.xml · derivative · entry 1 Zikria Dean · CIK 0001877611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-12-13 F1 · derivative.exercise_date: The option will vest one year from the grant date. Read SEC document |
| December 14, 2021 Filed Dec 17, 2021 01:37 UTC |
Bolton SheryleDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $4.59 | $0.00 |
DisclosureSEC source: 0001104659-21-150711 · tm2135733d1_4.xml · derivative · entry 1 Bolton Sheryle · CIK 0001418947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-12-13 F1 · derivative.exercise_date: The option will vest one year from the grant date. Read SEC document |
| December 14, 2021 Filed Dec 17, 2021 01:39 UTC |
Drexler KarenDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $4.59 | $0.00 |
DisclosureSEC source: 0001104659-21-150715 · tm2135733d5_4.xml · derivative · entry 1 Drexler Karen · CIK 0001504699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-12-13 F1 · derivative.exercise_date: The option will vest one year from the grant date. Read SEC document |
| December 14, 2021 Filed Dec 17, 2021 01:38 UTC |
Gurfein BlakeChief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 82,500 | $0.00 Strike: $4.59 | $0.00 |
DisclosureSEC source: 0001104659-21-150714 · tm2135733d4_4.xml · derivative · entry 1 Gurfein Blake · CIK 0001891888 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,500 Underlying: Common Stock · 82,500 shares Expires 2031-12-13 F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months. Read SEC document |
| December 14, 2021 Filed Dec 17, 2021 01:37 UTC |
Sabia RyanVP of Sales and Operations
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $4.59 | $0.00 |
DisclosureSEC source: 0001104659-21-150712 · tm2135733d2_4.xml · derivative · entry 1 Sabia Ryan · CIK 0001892415 · VP of Sales and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-12-13 F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months. Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 21:11 UTC |
Ernst JenniferDirector · Chief Executive Officer · 10% owner
|
ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $3.75 | $101,200.00 |
DisclosureSEC source: 0001104659-21-139507 · tm2133057-1_4seq1.xml · derivative · entry 4 Ernst Jennifer · CIK 0001889915 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,986 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the "Note"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount. F2 · price: On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the "Note"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount. F2 · derivative.exercise_date: On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the "Note"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount. F3 · derivative.expiration_date: The Note was scheduled to mature on June 1, 2023. Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 21:11 UTC |
Ernst JenniferDirector · Chief Executive Officer · 10% owner
|
ConversionSeries Seed-2 Convertible Preferred Stock · Derivative | 5,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-139507 · tm2133057-1_4seq1.xml · derivative · entry 3 Ernst Jennifer · CIK 0001889915 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the "IPO"). The Series Seed-2 Convertible Preferred Stock had no expiration date. F1 · price: The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the "IPO"). The Series Seed-2 Convertible Preferred Stock had no expiration date. F1 · derivative.expiration_date: The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the "IPO"). The Series Seed-2 Convertible Preferred Stock had no expiration date. Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 21:11 UTC |
Ernst JenniferDirector · Chief Executive Officer · 10% owner
|
ConversionCommon Stock | 26,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-139507 · tm2133057-1_4seq1.xml · nonDerivative · entry 2 Ernst Jennifer · CIK 0001889915 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,199,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the "Note"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount. F2 · price: On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the "Note"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount. Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 21:11 UTC |
Ernst JenniferDirector · Chief Executive Officer · 10% owner
|
ConversionCommon Stock | 1,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-139507 · tm2133057-1_4seq1.xml · nonDerivative · entry 1 Ernst Jennifer · CIK 0001889915 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,172,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the "IPO"). The Series Seed-2 Convertible Preferred Stock had no expiration date. F1 · price: The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the "IPO"). The Series Seed-2 Convertible Preferred Stock had no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.